publication venue for
- Membranoproliferative glomerulonephritis in Takayasu's arteritis. 1988
- Pulmonary calcification in long-term hemodialysis: a mimic of pulmonary thromboembolism. 1984
- Availability and Affordability of Kidney Health Laboratory Tests around the Globe.. 51. 2020
- Chronic Kidney Disease Awareness and Longitudinal Health Outcomes: Results from the REasons for Geographic And Racial Differences in Stroke Study.. 51. 2020
- Efficacy and Safety of Sodium Zirconium Cyclosilicate for Treatment of Hyperkalemia: An 11-Month Open-Label Extension of HARMONIZE.. 50. 2019
- Percutaneous Coronary Intervention Does Not Lower Cardiovascular Outcomes in Patients with Chronic Kidney Disease.. 50. 2019
- Interstitial Immunostaining and Renal Outcomes in Antineutrophil Cytoplasmic Antibody-Associated Glomerulonephritis.. 46. 2017
- Smoking-related glomerulopathy: expanding the morphologic spectrum.. 41. 2015
- Healthy behaviors, risk factor control and awareness of chronic kidney disease.. 37. 2013
- Polymorphisms in the nonmuscle myosin heavy chain 9 gene (MYH9) are associated with albuminuria in hypertensive African Americans: the HyperGEN study.. 29. 2009
- Nicotine augments glomerular injury in a rat model of acute nephritis.. 29. 2008
- C.E.R.A. maintains stable control of hemoglobin in patients with chronic kidney disease on dialysis when administered once every two weeks.. 28. 2007
- Hyponatremia in community-acquired pneumonia.. 27. 2007
- Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathy.. 24. 2003
- The effects of sevelamer and calcium acetate on proxies of atherosclerotic and arteriosclerotic vascular disease in hemodialysis patients.. 23. 2003
- Angiotensin-converting enzyme inhibition induces death receptor apoptotic pathways in erythroid precursors following renal transplantation.. 23. 2003
- Effect of angiotensin-converting enzyme inhibitors on response to erythropoietin therapy in chronic dialysis patients.. 18. 1998
- The practical aspects of therapy with rHuEPO.. 10 Suppl 2. 1990
- Absolute cardiovascular risk: the basis for deciding to treat. 1996